Pulmonary arterial hypertension (PAH) is a serious pathological phenomenon with poor
prognosis, which is associated with morphological as well as hemodynamic alteration of the …

At present, six groups of chronic pulmonary hypertension (PH) are described. Among these,
group 1 (and 1′) comprises a group of diverse diseases termed pulmonary arterial …

Pulmonary arterial hypertension (PAH) is a severe form of pulmonary hypertension that
combines multiple alterations of pulmonary arteries, including, in particular, thrombotic and …

Numerous animal models of pulmonary hypertension (PH) are currently used to evaluate
new therapies; investigating both their efficacy and the mechanism of their effect. They are …

Pulmonary arterial hypertension (PAH) is a rare disease of the pulmonary vasculature
characterized by endothelial cell apoptosis, smooth muscle proliferation and obliteration of …

INTRODUCTION: Pulmonary arterial hypertension (PAH) is a rare syndrome of fatigue and
dyspnoea, caused by increased pulmonary vascular resistance and right heart failure …

Pulmonary arterial hypertension (PAH) is a rare disease characterized by significant
vascular remodeling within the lung. Clinical computed tomography (CT) scans are routinely …

Abstract World Health Organization category 1 pulmonary hypertension (PH) is a
heterogeneous syndrome in which PH originates in the small pulmonary arteries and is …

Pulmonary arterial hypertension (PAH) is a disorder predominantly affecting the small
pulmonary arteries. It can occur without an identifiable cause, primary pulmonary …

Rationale: The complex pathologies associated with severe pulmonary arterial hypertension
(PAH) in humans have been a challenge to reproduce in mice due to the subtle phenotype …